VVOS Latest Press Releases

-- October 21, 2026 --

Vivos Therapeutics Reports Nasdaq Confirmation of Compliance with Continued Listing Shareholders' Equity Standard Globe Newswire 7:00 AM

-- October 19, 2026 --

Vivos Therapeutics Closes Acquisition of Stake in SOD Sciences and 50% Interest in Pseudohypoxia Test, Opening a Potential Path to Access More Than 325,000 New Patients Through the AHA Channel Globe Newswire 5:01 PM

-- October 15, 2026 --

Vivos Therapeutics Agrees to Acquire Minority Stake in SOD Sciences and 50% Interest in Proprietary Pseudohypoxia Test Globe Newswire 8:45 AM

-- September 29, 2026 --

Vivos Therapeutics Reports Progress in Material Cost Reductions and Revenue Growth Initiatives Globe Newswire 8:45 AM

-- September 8, 2026 --

Vivos Therapeutics Announces Material Debt Reduction Globe Newswire 8:45 AM

-- August 28, 2026 --

Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center Globe Newswire 8:45 AM

-- August 25, 2026 --

Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers Globe Newswire 8:45 AM

-- August 20, 2026 --

Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment Globe Newswire 10:24 AM

-- August 14, 2026 --

Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update Globe Newswire 4:28 PM

Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call Globe Newswire 8:45 AM

-- August 11, 2026 --

Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations Globe Newswire 8:45 AM

-- August 5, 2026 --

Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology Globe Newswire 8:30 AM

-- June 30, 2026 --

Vivos' Vida Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants Globe Newswire 8:45 AM

-- June 22, 2026 --

Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity Globe Newswire 8:30 AM

-- June 11, 2026 --

Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering Globe Newswire 8:30 AM

-- June 10, 2026 --

Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients Globe Newswire 9:03 AM

-- June 8, 2026 --

Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026 Globe Newswire 1:39 PM

-- June 5, 2026 --

Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing Globe Newswire 8:45 AM

Market Data Delayed 15 Minutes